Preliminary clinical assessment and non- toxicity evaluation of an ayurvedic formulation BGR-34 in NIDDM.

Gupta, B P; Sharma, I; Kohli, N; Sharma, S; Rathi, A; Sharma, A K

Gupta, B P; Sharma, I; Kohli, N; Sharma, S; Rathi, A; Sharma, A K.

Affiliation

Gupta BP; Aggarwal Dharmarth Hospital, New Delhi, India.
Sharma I; Research and Development, Aimil Pharmaceuticals (India) Ltd, New Delhi, India.
Kohli N; Aimil Healthcare and Research Centre, New Delhi, India.
Sharma S; Research and Development, Aimil Pharmaceuticals (India) Ltd, New Delhi, India.
Rathi A; Research and Development, Aimil Pharmaceuticals (India) Ltd, New Delhi, India.
Sharma AK; Research and Development, Aimil Pharmaceuticals (India) Ltd, New Delhi, India.

J Tradit Complement Med ; 8(4): 506-514, 2018 Oct.

Article in En | MEDLINE | ID: mdl-30302331

Key words

ALP, alkaline phosphatase; BBN, total bilirubin; BGR-34; Berberis aristata; CPCSEA, committee for the purpose of conduct and supervisions of experiments on rats; CSIR, council of scientific & industrial research, india; CTRI, clinical trial registry-India; DLC, differential leukocyte count; FPG, fasting plasma glucose; HDL, high-density lipoproteins; Hb, haemoglobin; HbA1c, glycosylated haemoglobin; Indian system medicine; NIDDM; NIDDM, noninsulin-dependent diabetes mellitus; OECD, organization for economic co-operation and development; OHGAs, other oral hypoglycemic agents; OPD, out Patient Department; PPBG, post-prandial blood glucose; SGOT, serum glutamate oxaloacetate transaminase; SGPT, serum glutamate pyruvate transaminase; TLC, TOTAL leukocyte count; Type 2 diabetes

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: J Tradit Complement Med Year: 2018 Document type: Article

Fulltext

XML

PubMed Links

Search on Google